Humankind Investments’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-8,162
| Closed | -$294K | – | 142 |
|
|
2023
Q1 | $294K | Buy |
8,162
+966
| +13% | +$34.8K | 0.12% | 90 |
|
|
2022
Q4 | $284K | Buy |
7,196
+234
| +3% | +$9.25K | 0.12% | 93 |
|
|
2022
Q3 | $280K | Buy |
6,962
+460
| +7% | +$18.5K | 0.14% | 87 |
|
|
2022
Q2 | $273K | Sell |
6,502
-184
| -3% | -$7.73K | 0.13% | 83 |
|
|
2022
Q1 | $260K | Buy |
6,686
+564
| +9% | +$21.9K | 0.11% | 97 |
|
|
2021
Q4 | $244K | Buy |
6,122
+269
| +5% | +$10.7K | 0.31% | 92 |
|
|
2021
Q3 | $212K | Buy |
+5,853
| New | +$212K | 0.32% | 90 |
|